IGeneX
IGeneX: A Leader in Tick-Borne Disease Diagnostics
IGeneX Inc. is a globally recognized leader in diagnosing tick-borne diseases, including Lyme disease, Tick-Borne Relapsing Fever (TBRF), and co-infections. Known for providing accurate, comprehensive, and reliable testing, IGeneX is at the forefront of advancing diagnostic solutions for these complex and often misdiagnosed conditions.
About the Founding and Mission of IGeneX
Founded in 1991 and headquartered in Milpitas, California, IGeneX was established by Dr. Nick Harris, a trailblazer in Lyme disease diagnostics. The company is driven by its mission to develop more advanced diagnostic tools that improve the detection of tick-borne pathogens and offer accurate diagnostics to aid in patient care.
Innovation and Science at IGeneX
IGeneX leverages state-of-the-art testing methodologies, including ImmunoBlot technology, to provide highly accurate diagnostics for Lyme disease and other tick-borne illnesses. The Lyme ImmunoBlot test, for instance, offers superior sensitivity compared to conventional tests like ELISA and Western Blot. IGeneX’s innovative approach enables the detection of a broader range of Borrelia strains and species, making it a trusted name in diagnostics.
IGeneX has also pioneered the use of Fluorescence In Situ Hybridization (FISH) technology, which was instrumental in identifying Borrelia burgdorferi in California and Babesia in regions such as New York, Switzerland, and Australia.
Comprehensive Testing Services Offered by IGeneX
IGeneX offers a wide array of diagnostic tests to detect Lyme disease, co-infections, and other tick-borne illnesses. Their tests are designed to provide a thorough evaluation of both immune response and active infections, allowing for more accurate diagnosis and personalized treatment.
Key Diagnostic Tests Available:
-
Lyme ImmunoBlot IgG + IgM
This test detects antibodies to various strains of Borrelia burgdorferi with greater sensitivity, offering accurate results in both early and late stages of Lyme disease. -
Lyme IGXSpot
A sensitive assay that detects T cells specific to Borrelia, helping to diagnose infections in seronegative patients or those with early-stage Lyme disease. -
Tick-Borne Disease Panel
A comprehensive panel that tests for Lyme disease, Babesiosis, Bartonellosis, Rickettsiosis, and other common tick-borne illnesses. -
Lyme PCR Panel
This test identifies active Lyme disease by detecting Borrelia DNA directly from blood samples. -
ImmunoBlot Panel
Multiple ImmunoBlot panels are available to detect various stages of immune response to tick-borne pathogens.
Transition to Advanced Diagnostic Technology
IGeneX has moved beyond traditional Western Blot testing, adopting advanced ImmunoBlot technology for more precise diagnostics. Unlike the older Western Blot, which can have limited sensitivity, the IGeneX ImmunoBlot offers enhanced accuracy by detecting multiple pathogens simultaneously and using engineered proteins for better specificity. This transition represents a significant advancement in the field of Lyme disease diagnostics.
Commitment to Education
Beyond diagnostics, IGeneX is deeply committed to educating patients, healthcare providers, and the broader community about tick-borne diseases. The company collaborates closely with clinicians and researchers to ensure that the latest advancements in testing and treatment are accessible to all. This dedication extends to physician training and public awareness programs, helping to improve diagnosis and management of Lyme disease and co-infections.
Quality Assurance and Accreditations
IGeneX holds certifications from CLIA and complies with stringent state licensing requirements, ensuring that their diagnostic tests meet the highest standards of quality and safety. The company’s commitment to excellence ensures that patients and healthcare providers can trust the reliability and accuracy of their test results.
Why IGeneX is a Top Choice for Tick-Borne Disease Testing
Choosing IGeneX for tick-borne illness testing provides numerous benefits, including:
- Comprehensive Diagnostic Panels: IGeneX offers a wide range of tests for Lyme disease and co-infections, ensuring a thorough evaluation.
- Advanced Technology: With its use of ImmunoBlot and PCR technology, IGeneX offers the most accurate diagnostics available.
- Educational Outreach: IGeneX is committed to educating both patients and healthcare providers, empowering them with the knowledge to manage and treat tick-borne illnesses effectively.
Conclusion: IGeneX’s Impact on Tick-Borne Disease Diagnosis
With its dedication to advancing research, deploying innovative technology, and supporting patient and practitioner education, IGeneX Inc. has cemented its position as a leader in tick-borne disease diagnostics. By offering comprehensive testing and championing awareness and collaboration, IGeneX remains an essential resource in the fight against Lyme disease and other tick-borne infections.
Show more